Call MEDISCA now at 1-800-932-1039 1-800-932-1039

MEDISCA News at Your Fingertips

MEDISCA Launches New Thyroid API - Now Available to Compounding Pharmacists after Years of Industry-wide Disruptions to Supply.


PLATTSBURGH, N.Y. (August 26, 2021) - MEDISCA has officially begun accepting orders for its long-awaited thyroid active pharmaceutical ingredient (thyroid API), creating a consistent supply for compounding pharmacists, prescribers and of course, their patients.

MEDISCA and fellow industry leaders lobby for revisions to compounded expiry dates and succeed


Over the last several months, MEDISCA Australia along with other industry leaders have been actively putting forward to the Australian Pharmaceutical Formulary & Handbook (APF), scientific rationale for longer expiry dates for compounded preparations. Medisca is now pleased to see the efforts of the compounding community come to fruition.

MEDISCA $100,000 pledge to protect compounded hormone therapy encourages industry-wide response - doubling donations in 1 month.


Earlier this year MEDISCA announced that in June it would match up to $100,000 in donations to the Alliance for Pharmacy Compounding (APC) Media Fund Campaign, encouraging investments to support APC’s nationwide marketing and lobbying effort to secure compounded hormone therapy. The result was astonishing, bringing in $113,545 in investments from compounding pharmacies, which, with Medisca’s match, elevated the final amount raised in June to $213,545.

MEDISCA strategic partnership stabilizes industry supply of thyroid API


MEDISCA has finalized an exclusive distribution agreement with pharmaceutical manufacturer Sichuan Deebio Pharmaceutical Co.,Ltd to provide thyroid active pharmaceutical ingredient (API) to the compounding and non-compounding industries in the United States. This agreement will bring much-needed stability to a market that has seen inconsistent supply for several years.

MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications


MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications.

MEDISCA Sponsors LP3 Network’s Virtual Student Event Drawing Over 350 Pharmacy Students Worldwide


On March 19, 2021, future pharmacists from over 35 colleges came together to participate in a live FREE Virtual Student Event sponsored by Medisca, a global leader in the compounding pharmaceutical industry. The event, created and hosted by LP3 Network, attracted over 350 students from more than 10 countries and sought to promote the industry through interactive discussions and first-hand narratives about the vital role that compounding pharmacies played during the COVID-19 pandemic.




We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.

Copyright® 1989-2021 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified Drug Distributor